EU reshapes HTAs: is the industry ready for it?
New EU regulations aim to speed up health technology assessments (HTAs), but the pharma industry raises logistical concerns.

New EU regulations aim to speed up health technology assessments (HTAs), but the pharma industry raises logistical concerns.
The UK announced the funding at the AI Action Summit in Paris where it abstained from signing a declaration on an inclusive approach to AI.
The pharmaceutical industry continues to be a hotbed of patent innovation. Activity is driven by the evolution of treatment paradigms,...
Pharma Technology Focus is our digital magazine, free to read online on all devices. Click the magazine cover to read the latest issue. You can subscribe for free to have each new issue delivered to your inbox.
The AI advantage in discovering new medicines
AI’s potential in women’s health exciting, says Gates Foundation leader
Shionogi awarded $375m from HHS for preventative Covid-19 injectable
Pfizer believes in the metaverse: will healthcare thaw the technology’s winter?